Evidence map›Paper›PMID 28189783›Full record

ReviewPharmacological research2017

Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.

Joelle N Zambrano, Benjamin A Neely, Elizabeth S Yeh

Abstract readReview
In one paragraph

Review in Pharmacological research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Biomedicines · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Joelle N ZambranoDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina Charleston, SC, USA. Electronic address: zambrano@musc.edu.
Benjamin A NeelyMarine Biochemical Sciences, National Institute of Standards and Technology, Charleston, SC, USA. Electronic address: benjamin.neely@nist.gov.
Elizabeth S YehDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina Charleston, SC, USA. Electronic address: yeh@musc.edu.
Medical University of South Carolina · USNational Institute of Standards and Technology · US

Funding

SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
MUSC Minority Student Development ProgramR25GM072643 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2005 to 2023
$5.8M
Overcoming Resistance in HER2-positive Breast CancerR01CA187305 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YEH, ELIZABETH S · 2015 to 2019
$1.8M
NCI NIH HHS R01 CA187305NIGMS NIH HHS P20 GM103542NIGMS NIH HHS R25 GM072643
6 · The paper itself

Abstract

Hormonally up-regulated neu-associated Kinase (Hunk) is a protein kinase that was originally identified in the murine mammary gland and has been shown to be highly expressed in Human Epidermal Growth Factor Receptor 2 positive (HER2

Indexed as

AnimalsAntineoplastic AgentsBreastBreast NeoplasmsDrug Resistance, NeoplasmErb-b2 Receptor Tyrosine KinasesFemaleHumansMolecular Targeted TherapyNeoplasm MetastasisProtein Serine-Threonine KinasesAntineoplastic AgentsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesHUNK protein, humanProtein Serine-Threonine KinasesBreast cancerDrug resistanceHER2/ErbB2HunkProtein kinase

Identifiers

PMID28189783
PMCPMC5392418
OpenAlexW2587141892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.